Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 26052
MIM: 611445
HGNC: 29125
Ensembl: ENSG00000197959
Variants:
dbSNP: 26052
ClinVar: 26052
TCGA: ENSG00000197959
COSMIC: DNM3
RNA/Proteins
Expression (GTEx)
Pathways
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 36528667 | 2022 | Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors. | 3 |
| 36528667 | 2022 | Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors. | 3 |
| 32873436 | 2021 | Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's disease. | 9 |
| 33622874 | 2021 | TBX15 rs98422, DNM3 rs1011731, RAD51B rs8017304, and rs2588809 Gene Polymorphisms and Associations With Pituitary Adenoma. | 1 |
| 32873436 | 2021 | Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's disease. | 9 |
| 33622874 | 2021 | TBX15 rs98422, DNM3 rs1011731, RAD51B rs8017304, and rs2588809 Gene Polymorphisms and Associations With Pituitary Adenoma. | 1 |
| 32573516 | 2020 | The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis. | 4 |
| 32573516 | 2020 | The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis. | 4 |
| 30133089 | 2019 | No association of DNM3 with age of onset in Asian Parkinson's disease. | 2 |
| 30340792 | 2019 | No evidence for DNM3 as genetic modifier of age at onset in idiopathic Parkinson's disease. | 0 |
| 30133089 | 2019 | No association of DNM3 with age of onset in Asian Parkinson's disease. | 2 |
| 30340792 | 2019 | No evidence for DNM3 as genetic modifier of age at onset in idiopathic Parkinson's disease. | 0 |
| 27837435 | 2017 | Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma. | 62 |
| 27837435 | 2017 | Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma. | 62 |
| 26784388 | 2016 | DNM3 Attenuates Hepatocellular Carcinoma Growth by Activating P53. | 22 |
Citation
Dessen P
DNM3 (dynamin 3)
Atlas Genet Cytogenet Oncol Haematol. 2014-08-01
Online version: http://atlasgeneticsoncology.org/gene/54259/dnm3-(dynamin-3)
